Abnormalities of the Immune System in Cancer Patients
January 19, 2022
Please note, with the fast developing knowledge of COVID-19, some recommendations may change as new data emerges. Click here to access the latest LLS information and resources on COVID-19.
We invite you to learn more about:
- Immune deficiency in blood cancer patients
- How infections are treated
- COVID-19 treatments and vaccinations
- Shared decision making with your treatment team
S. Shahzad Mustafa, MD
Chief of Allergy, Immunology, and Rheumatology
Rochester Regional Health
Clinical Associate Professor of Medicine
University of Rochester School of Medicine
This local program is posted nationally as part of LLS’s Covid Response Program, which is supported in part by BeiGene, Bristol Myers Squibb, Kite, A Gilead Company, Pfizer and Pharmacyclics, an AbbVie Company & Janssen Biotech.
For any questions or comments about this program, please email feedback@LLS.org.